AFLFinancial Services · Insurance - LifeThe 14 Wall Street analysts covering Aflac, Inc. hold a median 12-month price target of $118 — -6.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 68 of 100 as at 1 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Aflac, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (94): The share price has been relatively steady.
Value (32): The shares cost a lot relative to the profits and assets behind them.
Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own Aflac, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on AFL, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits −6.9% from it.
Of the 20 most recent actions, 7 moved their price target up and 1 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 22 July 2026 | TD Cowen | Maintains | Hold | $101 → $110 |
| 21 July 2026 | JP Morgan | Maintains | Neutral | $108 → $117 |
| 13 July 2026 | Evercore ISI Group | Maintains | Underperform | $109 → $115 |
| 13 July 2026 | Evercore ISI Group | Maintains | Underperform | — |
| 13 July 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | — |
| 13 July 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | $115 → $120 |
| 10 July 2026 | Jefferies | Maintains | Hold | — |
| 10 July 2026 | Jefferies | Maintains | Hold | $100 → $108 |
| 9 July 2026 | Mizuho | Maintains | Underperform | — |
| 9 July 2026 | Wells Fargo | Maintains | Equal-Weight | $111 → $120 |
| 9 July 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 8 July 2026 | UBS | Maintains | Neutral | — |
| 8 July 2026 | UBS | Maintains | Neutral | $114 → $124 |
| 7 July 2026 | Barclays | Maintains | Underweight | — |
| 7 July 2026 | Barclays | Maintains | Underweight | $99 → $98 |
| 26 May 2026 | Piper Sandler | Maintains | Overweight | — |
| 21 May 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 5 May 2026 | Wells Fargo | Maintains | Equal-Weight | — |
| 1 May 2026 | Piper Sandler | Maintains | Overweight | — |
| 30 Apr 2026 | Barclays | Maintains | Underweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 48% of US stocks
Cheaper than 34% of US stocks
Cheaper than 44% of US stocks
Cheaper than 32% of US stocks
Higher than 79% of US stocks
Higher than 99% of US stocks
Higher than 88% of US stocks
Higher than 86% of US stocks
Higher than 77% of US stocks
Higher than 66% of US stocks
Higher than 44% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AFL appears on the weeks it earns a place.
Aflac's improved Japan benefit-to-premium ratio may help offset premium and investment income pressure ahead of its Aug. 6 second-quarter earnings report, according to Zacks Investment Research.
Why it matters — Aflac watchers would care because the Japan segment's profitability could influence the company's upcoming Q2 results.
A Zacks Investment Research piece previews Aflac's expected performance for the quarter ended June 2026, looking beyond standard top-and-bottom-line estimates at several key metrics for better insight into the company's results.
Why it matters — Aflac watchers can get a view of which specific business metrics are likely to be closely watched when the company reports results for the June 2026 quarter.
A Zacks Investment Research report suggests Aflac (AFL) has the right combination of key ingredients for a likely earnings beat in its upcoming earnings report.
Why it matters — AFL watchers monitoring the company's earnings performance would care about this report's expectation of a potential earnings beat.
The 14 Wall Street analysts covering Aflac, Inc. have a median 12-month price target of $118, with estimates ranging from $98 to $137. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 14 analysts covering Aflac, Inc., 3 rate it a Buy, 8 a Hold and 3 a Sell. Ticker Nerd's systematic factor model ranks Aflac, Inc. 68 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, Aflac, Inc. ranks 68 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (94 of 100).
No one can know that. What the data says: the median 12-month target from 14 analysts implies -6.9% from the last close, and Ticker Nerd's factor model ranks Aflac, Inc. 68 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Aflac, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AFL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $98 to $137 over the next 12 months.
Aflac, Inc. returned +31.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Aflac Inc. is a financial services holding company specializing in supplemental health and life insurance.
The most recent item we track (Zacks Investment Research, 3 Aug 2026): "Can Better Japan Profitability Support Aflac's Q2 Earnings Beat?". Aflac's improved Japan benefit-to-premium ratio may help offset premium and investment income pressure ahead of its Aug. 6 second-quarter earnings report, according to Zacks Investment Research.
Aflac Inc. is a financial services holding company specializing in supplemental health and life insurance. The company primarily operates through two segments, Aflac Japan and Aflac U.S., providing insurance products that help policyholders manage out-of-pocket costs not fully covered by primary medical plans. Aflac is best known for its supplemental policies, including cancer insurance, accident coverage, critical illness plans, hospital indemnity, disability, and long-term care offerings. These products are marketed largely through independent agents and brokers, with a strong presence in worksite distribution, where policies are offered to employees through their employers, as well as through digital and direct-to-consumer channels. Headquartered in Columbus, Georgia, Aflac serves individuals and businesses, playing a notable role in the insurance market by focusing on financial protection against unexpected health-related expenses in both the United States and Japan.
CEO Mr. Daniel Paul Amos · 12,716 employees · United States · https://www.aflac.com